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Abstract
Gingival enlargement or overgrowth is a common disease of gingiva. The causative 
factors may range from inflammation due to local factors to conditioned enlargement 
and neoplastic enlargements. They commonly present as bulbous interdental gingival, 
diffuse swelling of gingival. Due to the unaesthetic appearance of the overgrown 
gingiva, treatment becomes inevitable. This results in excision of overgrowth known 
as gingivectomy. The first gingivectomy procedure was explained by Robicsek in 1884 
and later by Zentler (1918). Grant (1979) defined gingivectomy as excision of soft 
tissue wall of pathologic periodontal pocket. Gingivectomy procedures can be done by 
means of scalpel, laser, electrosurgery and chemosurgery. The ultimate result remains 
the same indifferent of the method used. However the amount of remaining keratin-
ized gingival and esthetic appearance is of supreme importance.
Keywords: gingival enlargement, gingival overgrowth, gingival hyperplasia, 
gingivectomy, gingival diseases, anticonvulsants, abscess
1. Introduction
Gingival enlargement is a common clinical problem, usually associated with 
specific conditions. This condition finds a unique place in literature, because it has 
been associated with a variety of local and systemic factors. Enlargement of any 
part, tissue or organ in the body may be attributable to one or more of the following 
pathological processes [1]:
Cellular hypertrophy: defined as an increase in the size of a part due to an increase 
in the size of the individual cells comprising that part.
Cellular hyperplasia: increase in size due to an increase in the absolute number of 
cells, though cell size is not altered.
Fibrosis: an accumulation of collagenous connective tissue which is classically 
characterized by relative acellularity.
Edema: it is nothing more than the presence of abnormally large amounts of 
fluid in the intercellular spaces.
The events leading to gingival enlargement are complex.
2. Classification
1. According to etiologic factors and pathologic changes [2]:
• Inflammatory enlargements:
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 ○ Chronic
 ○ Acute
• Drug induced enlargements:
 ○ Anticonvulsants
 ○ Antihypertensive calcium antagonists
 ○ Immunosuppressant
• Idiopathic enlargement
• Enlargements associated with systemic diseases:
Conditioned enlargements
• Pregnancy
• Puberty
• Vitamin C deficiency
• Plasma cell gingivitis
• Non-specific conditioned enlargement (pyogenic granuloma)
Systemic diseases causing gingival enlargement:
• Leukemia
• Granulomatous diseases (Wegener’s granulomatosis, sarcoidosis, etc.)
• Neoplastic enlargements: (gingival tumors)
 ○ Benign tumors
 ○ Malignant tumors
• False enlargements
2. According to location and distribution:
• Localized: limited to the gingiva of a single or group of teeth.
• Generalized: involving gingiva throughout the mouth.
• Marginal: confined to the gingival margin.
• Papillary: confined to the interdental papilla.
• Diffuse: involving marginal and attached gingiva and papilla.
• Discrete: an isolated sessile or pedunculated or tumor like enlargement.
Scoring of gingival enlargement:
• Grade 0: no signs of gingival enlargement.
• Grade I: enlargement confined to interdental papilla.
• Grade II: enlargement involves papilla and marginal gingiva.
• Grade III: enlargement covers three quarters or more of the crown.
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3. Clinical features
3.1 Inflammatory enlargement
It may be chronic or acute. This usually results from accumulation of local 
deposits. Factors resulting in plaque accumulation predisposes to inflammatory 
enlargement. Chronic inflammatory enlargement originates as slight ballooning 
of interdental papilla and marginal gingival. A life preserver shaped bulge appears 
around the involved teeth. This can increase in size until it covers the crown. It is 
usually painless until trauma or acute infection is superimposed [2].
Inflammatory enlargement may be localized or generalized. Localized enlarge-
ment may appear as tumor like mass or nodule, sessile or pedunculated. It may 
involve interdental papilla, marginal gingival or attached gingiva. They may 
undergo spontaneous reduction in size, followed by exacerbation and continued 
enlargement. Painful ulceration sometimes occurs in the fold between the mass 
and the adjacent gingiva [2]. Chronic inflammatory enlargement may also occur 
because of presence of mouth breathing habits. Anterior region predominantly 
papilla is involved. The mouth breathing habit results in dryness of the mucosa. 
There is a clear demarcation between normal and involved gingival [2] (Figure 1).
3.2 Acute inflammatory enlargement
Acute form of gingival enlargement includes abscesses of the periodontium. 
They results in a localized painful area of purulent material which needs to be 
drained. Lindhe et al. [3] classified as (a) periodontitis-related abscess, infection 
caused by the bacteria present at the subgingival biofilm in a deepened periodontal 
pocket, (b) non-periodontitis-related abscess, infection caused by the bacteria 
originating from another local source, such as a foreign body impaction or from 
alterations in the integrity of the root leading to bacteria colonization. Meng [4] 
classified as gingival abscesses (in previously healthy sites and caused by impaction 
of foreign bodies), periodontal abscesses (either acute or chronic, in relation to a 
periodontal pocket), and pericoronal abscesses (at incompletely erupted teeth). 
The gingival abscess involves the marginal gingival and interdental tissues. The 
periodontal abscess is an acute destructive process in the periodontium, resulting in 
the localized collection of pus, communicating with the oral cavity through gingival 
sulcus or other periodontal sites and not arising from tooth pulp. The pericoronal 
abscess is associated with the crown of a partially erupted tooth [4, 5].
Periodontal abscess (Figure 2) formation may occur in the following ways [6]:
1. Extension of infection from a periodontal pocket deeply into the supporting 
periodontal tissues, and localization of the suppurative inflammatory process 
along the lateral aspect of the root.
2. Lateral extension of inflammation from the inner surface of a periodontal 
pocket into the connective tissue of the pocket wall. Localization of the abscess 
results when drainage into the pocket space is impaired.
3. Formation in a pocket with a tortuous course around the root. A periodontal abscess 
may form in the cul-de-sac, the deep end of which is shut off from the surface.
4. Incomplete removal of calculus during treatment of a periodontal pocket. The 
gingival wall shrinks, occluding the pocket orifice, and a periodontal abscess 
occurs in the sealed-off portion of the pocket.
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3.3 Drug-induced gingival enlargement
The growth starts as painless bead like enlargement in the papillary region which 
extends on the facial and lingual region. As the overgrowth increases the massive 
fold of tissue can be observed covering considerable or entire portion of crown. 
This will result in one or more problems like difficulty in oral hygiene maintenance 
and mastication, may alter tooth eruption, interference of speech and esthetic 
issues [7, 8].
The clinical appearance reveals firm and fibrotic component unless superim-
posed by secondary infection because of lack of oral hygiene and biofilm accu-
mulation. These secondary changes include change in color of gingiva, increased 
bleeding tendency and superimposed inflammation obliterates the demarcation of 
the lobules [6].
Phenytoin induced gingival overgrowth (Figure 3) is characterized by granular 
or pebbly surface with enlargement of interdental papilla to an extent they result 
in pseudoclefts. The growth diminishes as they reach to the mucogingival junction 
but continue to grow in coronal direction resulting in partial or complete obscure 
of teeth [9]. The systemic administration of phenytoin accelerates the healing 
of gingival wounds in nonepileptic humans and increases the tensile strength of 
healing abdominal wounds in rats [10]. Cyclosporin induced enlargement appears 
to be more prominent on the labial surface, hyperemic, soft, friable and has high 
bleeding tendency. Calcium channel blocker (Figure 4) affects papillary region 
initially resulting into a lobular and nodular morphology extending to attached and 
marginal gingival. The inflammatory changes are associated leading to poor plaque 
control and esthetic concerns [11]. Gingival enlargement is greater in patients 
Figure 2. 
Periodontal abscess.
Figure 1. 
Chronic inflammatory enlargement.
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who are medicated with both cyclosporine and calcium channel blockers [12]. The 
microscopic finding of many plasma cells plus the presence of an abundant amor-
phous extracellular substance has suggested that the enlargement is a hypersensitiv-
ity response to the cyclosporine [13].
The probable mechanism include role of fibroblasts, inflammatory cytokines 
and matrix metalloproteinases (MMP). It has been seen that not all patients 
treated with these drugs show alteration in size of gingival rather some have very 
pronounced effect. It has been hypothesized that these individuals have fibroblasts 
with an abnormal susceptibility to the drug. Fibroblasts from overgrown gingiva in 
phenytoin-treated patients are characterized by elevated levels of protein synthesis, 
most of which is collagen. The susceptibility to enlargement is governed by presence 
of fibroblast subsets which are reactive to these medications [14].
A synergistic enhancement of collagenous protein synthesis by human gingival 
fibroblasts was found when these cells were simultaneously exposed to nifedipine 
and interleukin-1β (IL-1β), a proinflammatory cytokine that is elevated in inflamed 
gingival tissues. In addition to IL-1β, IL-6 may play a role in the fibrogenic responses 
of the gingiva to these medications. A reported histologic feature of cyclosporin-
induced gingival lesions is a elevation in the expression of IL-6 by cells within the 
gingival connective tissue. IL-6 appears to target connective tissue cells such as 
fibroblasts both by enhancing proliferation and by exerting a positive regulation on 
collagen and glycosaminoglycan synthesis [14].
It was also assumed that these drugs may interfere with the synthesis and func-
tion of collagenases. In support of this hypothesis, a recent in vitro study has shown 
that human gingival fibroblasts treated with clinically relevant cyclosporin doses 
Figure 4. 
Nifedipine induced gingival enlargement.
Figure 3. 
Phenytoin induced gingival enlargement.
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exhibit significantly reduced levels of MMP-1 and MMP-3 secretion; these reduced 
levels may contribute to the accumulation of extracellular matrix components [15].
3.4 Idiopathic gingival enlargement
It is an uncommon benign hereditary condition with no specific cause. It is char-
acterized by slow progressive firm and fibrous enlargement of gingiva. Synonyms 
are hereditary gingival fibromatosis, elephantiasis gingivae, congenital hypertrophy 
of gingiva, fibromatosis gingivae, congenital macrogingivae and hypertrophic 
gingiva. The color of the tissue appears pale pink, has characteristic leathery con-
sistency and pebbled surface (Figures 5 and 6). Exaggerated stippling is observed. 
The enlargement poses esthetic and functional irregularities. It may also lead to 
displacement of teeth. It affects attached, marginal and interdental gingiva. The 
genetic mechanisms are not well understood [16]. The gingival enlargement usually 
begins at the time of eruption of the permanent dentition but can develop with the 
eruption of the deciduous dentition and rarely is present at birth [17].
3.5 Conditioned enlargement
It occurs when the patient response to plaque accumulation is magnified because 
of the systemic condition of the patient.
Enlargement in pregnancy: it occurs as single or multiple tumor like masses in 
the marginal or attached gingiva. The hormonal change in the pregnancy leads to 
increased vascular permeability, gingival edema and increased response to dental 
plaque. The lesion appears as mushroom like, bleed easily, sessile or pedunculated, 
protruding from the margin or interproximal area. The lesion does not invade the 
bone and has pinpoint markings on the surface (Figure 7). The lesion usually grows 
till third trimester after which it may regress spontaneously [2]. The hormonal 
changes induce changes in vascular permeability, which leads to gingival edema and 
an increased inflammatory response to dental plaque. The subgingival microbiota 
may also undergo changes, including an increase in Prevotella intermedia [18].
Enlargement in puberty: Due to change in hormones during adolescences 
leads to aggravated response during puberty in areas of plaque accumulation. It is 
manifested as bulbous enlargement in the papillary region leading to enlargement 
in facial region, lingual region is relatively unaffected. The tendency for recurrence 
into massive enlargement in presence of scanty deposits differentiates it from 
chronic inflammatory enlargement [2].
A longitudinal study of 127 children between the ages of 11 and 17 years demon-
strated a high initial prevalence of gingival enlargement that tended to decline with 
Figure 5. 
Idiopathic gingival enlargement (left lateral).
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age [19]. Studies have reported that hormonal changes coincide with an increase in 
the proportion of Prevotella intermedia and Prevotella nigrescens [20, 21].
Plasma cell gingivitis: synonyms are atypical gingivitis and plasma cell gingivo-
stomatitis, it exhibits enlargement in marginal gingiva extending onto attached gin-
giva. Gingiva appears reddish, soft, friable, and sometimes granular and has high 
bleeding tendency; no loss of attachment is seen (if not periodontally involved). It 
is located in the facial aspect of the attached gingiva and thus distinguished from 
plaque-induced gingivitis [6]. In rare instances, marked inflammatory gingival 
enlargements with a predominance of plasma cells can appear; these are associated 
with rapidly progressive periodontitis [22].
3.6 Nonspecific conditioned enlargement
Pyogenic granuloma: it is a tumor-like enlargement of gingiva which is considered 
to be exaggerated conditioned response to minor trauma. The exact nature of the sys-
temic conditioning factor has not been identified [23]. The lesion varies from a discrete 
spherical, tumor-like mass with a pedunculated attachment to a flattened, keloid-like 
enlargement with a broad base. It is bright red or purple and either friable or firm, 
depending on its duration; in the majority of cases it presents with surface ulceration 
and purulent exudation (Figure 8). The lesion tends to involute spontaneously to 
become a fibroepithelial papilloma, or it may persist relatively unchanged for years [6].
3.7 Systemic diseases that cause gingival enlargement
Leukemia: leukemic enlargement is prominently because of accumulation of 
leukemic cells in the gingival. It manifests as diffuse or solitary and localized or 
Figure 6. 
Idiopathic gingival enlargement (right lateral).
Figure 7. 
Enlargement in pregnancy.
Gingival Disease - A Professional Approach for Treatment and Prevention
8
Figure 9. 
Epulis.
generalized. It may appear as either a diffuse enlargement of the gingival mucosa, 
an oversized extension of the marginal gingival or a discrete tumor-like inter-prox-
imal mass. In leukemic enlargement the gingiva is usually bluish red with a shiny 
surface. The consistency is moderately firm, but presents with a tendency towards 
friability and hemorrhage, occurring either spontaneously or on slight irritation 
[2]. Dreizen et al. found that cases with acute monocytic leukemia had the highest 
incidence of gingival infiltrates (M5) (66.7%) followed by acute myelomonocytic 
leukemia (M4) (18.5%) and acute myeloblastic leukemia (M1, M2) (3.7%) [24].
Wegener’s granulomatosis: it is a rare disease characterized by acute granuloma-
tous necrotizing lesions of the respiratory tract, including nasal and oral defects. It 
includes oral mucosal ulceration, gingival enlargement, abnormal tooth mobility, 
exfoliation of teeth, and delayed healing response [6]. The initial manifestations of 
Wegener’s granulomatosis may involve the orofacial region and include oral muco-
sal ulceration, gingival enlargement, abnormal tooth mobility, exfoliation of teeth, 
and delayed healing response [25].
4. Neoplastic enlargement (gingival tumors)
4.1 Benign tumors of the gingiva
Epulis: it is a generic term used clinically to designate all discrete tumors and 
tumor-like masses of the gingiva [2]. The term is used to explain the location of the 
tumor mass not to portray it. Most lesions referred to as “epulis” are inflammatory 
rather than neoplastic (Figure 9).
Figure 8. 
Pyogenic granuloma.
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Fibroma: fibromas of gingiva arise either from connective tissue of gingiva or 
from periodontal ligament. Fibromas are slow-growing, spherical tumors that tend 
to be firm and nodular but may be soft and vascular. Fibromas are usually peduncu-
lated. Hard fibromas of the gingiva are rare; most of the lesions diagnosed clinically 
as “fibromas” are inflammatory enlargements (Figure 10).
Papilloma: they are benign proliferations of surface epithelium associated with 
the human papillomavirus (HPV). Gingival papillomas appear as solitary, wart-like 
or cauliflower-like protuberances. They may be small and discrete or broad, hard 
elevations with minutely irregular surfaces.
Peripheral giant cell granuloma: giant cell lesions of the gingiva arise interden-
tally or from the gingival margin, occur most frequently on the labial surface, and 
may be sessile or pedunculated. They vary in appearance from smooth, regularly 
outlined masses to irregularly shaped, multilobulated protuberances with surface 
indentations. Ulceration of the margin is occasionally seen. The lesions are painless, 
vary in size, and may cover several teeth.
Central giant cell granuloma: these lesions arise within the jaws and produce 
central cavitation. They occasionally create a deformity of the jaw that makes the 
gingiva appear enlarged.
4.2 Malignant tumors of the gingiva
Squamous cell carcinoma is the most common malignant tumor of the gingiva. 
It may be exophytic, presenting as an irregular outgrowth, or ulcerative, appear-
ing as flat, erosive lesions. Malignant melanoma is a rare oral tumor that tends to 
occur in the hard palate and maxillary gingiva of older persons. It is usually darkly 
pigmented and is often preceded by localized pigmentation. Fibrosarcoma, lym-
phosarcoma, and reticulum cell sarcoma of the gingiva are rare; only isolated cases 
have been described in the literature [6].
4.3 False enlargement
False enlargements are not true enlargements of the gingival tissues but may 
appear as such as a result of increases in size of the underlying osseous or dental 
tissues. The gingiva usually presents with no abnormal clinical features except the 
massive increase in size of the area. It may be caused by increased underlying bone 
tissue or presence of normal underlying dental tissue [2].
4.4 Treatment
The treatment of gingival enlargement is based on the understanding of the 
cause and underlying pathology. The treatment differs for each type of enlargement 
Figure 10. 
Fibroma.
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based on the clinical and pathological signs and symptoms. The phase I therapy 
should be instituted before any surgical therapy.
4.5 Treatment protocol
The treatment protocol varies with each type of enlargement. Combinations of 
surgical and nonsurgical therapy are prevalent; used according to the need of the 
patient. The functional and esthetic demands should also be kept in mind.
4.5.1 Chronic inflammatory enlargement
These are presented as soft and edematous gingival tissues. The color changes 
are prominent with visibly reddish hue of the tissue. Bleeding is spontaneous. The 
therapy consists of thorough scaling and root planing and complete debridement of 
deposits [26]. This leads to shrinkage of tissue, slight if not complete.
Chronic gingival enlargement may also show fibrotic components; hence 
complete shrinkage of the tissue does not happen in such cases. Once the Phase I 
therapy has been instituted and gingival tissue does not return back to normal stage, 
surgical therapy should be considered. The surgical therapy consists of either gin-
givectomy procedures or/and flap operation. If the tissues are soft and edematous 
gingivectomy procedures are preferred. If the tissues are firm and fibrotic preferred 
treatment options is flap operation. The conservation of the keratinized, attached 
gingiva must be considered along with removal of the excessive gingival tissue [26].
During surgical procedure, the tissue is separated from the mucosa at its base by 
using a surgical blade. If the lesion extends interproximally, the interdental gingiva 
is included in the incision to ensure the exposure of deposits and form scalloped 
contour of gingiva. After complete removal of enlarged tissue and adequate acces-
sibility, the root surfaces are scaled and planed, and the area is irrigated. A peri-
odontal dressing is applied which is removed after a week. Depending on the extent 
of the surgery, the postoperative appointment may have to be scheduled in 2 weeks 
to allow for further healing. The healing is through secondary intention in gingivec-
tomy. In case of flap operation healing is through primary intention. After removal 
of excess tissue and elevation of mucoperiosteal flap, roots surface are debrided and 
sutures are given [6].
4.5.2 Periodontal and gingival abscesses
Periodontal and gingival abscesses results in acute enlargement of gingival 
which is usually localized around the area of the lesion, and the content of the 
enlarged area is purulent material, which must be drained and the area curetted. 
Drainage should be either from periodontal pocket or external incision [6].
4.5.3 Drainage through the periodontal pocket
The peripheral area around the abscess is adequately anesthetized. The pocket 
wall is gently retracted using a periodontal probe or curette in an attempt to initiate 
drainage through the pocket entrance. Gentle digital pressure and irrigation may be 
used to express the exudate and drain the pocket. Curette is inserted into the pocket 
entrance to establish drainage. Thorough scaling and root planing is done. If the 
lesion is large and drainage cannot be established, root debridement by scaling and 
root planing or surgical access should be delayed until the major clinical signs have 
abated. Prophylactic antibiotics should be given. Antibiotic therapy alone without 
subsequent drainage and subgingival scaling is contraindicated and avoided [26].
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4.5.4 Drainage through an external incision
The lesion is isolated and anesthetized. A vertical incision through the most 
fluctuant center of the abscess is made with a no. 15 surgical blade. The tissue adja-
cent to incision can be separated using a curette or periosteal elevator. The fluctuant 
matter is expressed, and the wound edges are approximated using mild digital 
pressure with a help of moist gauze pad. In abscesses manifesting with severe swell-
ing and inflammation, aggressive mechanical instrumentation should be delayed 
in favor of antibiotic therapy to avoid damage to surrounding healthy periodontal 
tissues. Patient is dismissed after bleeding and suppuration are controlled. Patients 
are advised for post-treatment plaque control measures [6].
4.5.5 Chronic abscess
The chronic abscess is treated with scaling and root planing and, if indicated, 
surgical therapy. Surgical treatment is considered when deep vertical pocket or 
furcation defects are observed that cannot be treated with mere nonsurgical instru-
mentation. Access to subgingival calculus is mandatory in areas of deep pockets [6].
4.5.6 Gingival abscess
Treatment of the gingival abscess is done to reverse the acute phase and immedi-
ate removal of the cause. As it is often seen that the lesion gets fluctuant, exudate 
is expressed and becomes symptomless and the cycle is repeated, the offending 
agent is to be removed. Topical or local anesthesia by infiltration is administered. 
When possible, scaling and root planing are completed to establish drainage and 
remove microbial deposits. In more acute situations, the fluctuant area is incised 
with a no. 15 scalpel blade, and exudate may be expressed by gentle digital pres-
sure. Any foreign material (offending agent e.g., dental floss, impression material) 
is removed. The area is irrigated with normal saline and covered with moist gauze 
under light pressure. Once bleeding is controlled, the patient is dismissed with post 
treatment instructions. The area is to be reassessed after 24 hours and if resolution 
is sufficient, scaling not previously completed is done. If the residual lesion is large 
or poorly accessible, surgical access may be required [26].
4.6 Drug-induced gingival enlargement
The examination of drug-induced gingival enlargement patient shows two 
components of the overgrown tissues which are either fibrotic, due to action of the 
drug on the physiologic gingival collagen turnover; or inflammatory, because of the 
presence of bacterial biofilm. Though the fibrotic and inflammatory changes pres-
ent in the enlarged gingiva are the consequences of distinct pathologic processes, 
they almost always are observed as gingival enlargement induced by the combina-
tion of drugs and biofilm [6].
The role of bacterial biofilm in the overall pathogenesis of drug-induced gin-
gival enlargement is not clear. Some studies indicate that biofilm is a prerequisite 
for gingival enlargement, whereas others suggest that the presence of biofilm is a 
consequence of biofilm accumulation caused by the enlarged gingiva [27].
The treatment of drug-induced gingival enlargement should be undertaken in 
consideration the medication used by the patient and the clinical features of the 
case. First, discontinuation of the drug or alternate medication should be consid-
ered. Consultation with the patient’s physician is warranted for any such possibili-
ties. It is not practically possible to completely discontinue the offending drug, 
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but alternate substitute of the drug may be an option. If any drug substitution is 
attempted, a time period of 6- to 12-month should be stalled between discontinua-
tion of the offending drug and substitution with an alternative drug [2].
Along with this, oral hygiene instructions, scaling, and root planing should 
always be instituted. Reevaluation of the gingival enlargement after the alteration 
of drug therapy and planning of surgical treatment should be done. Alternative 
medications to the anticonvulsant phenytoin include carbamazepine and valproic 
acid, both of which have been reported to induce gingival enlargement to a lesser 
degree. A murine study suggested that lovastatin may attenuate the onset of 
gingival enlargement induced by phenytoin [28]. Further research is necessary to 
confirm the therapeutic value of lovastatin. For patients who are taking nifedip-
ine, which has a reported prevalence of gingival enlargement of up to 86%, other 
calcium channel blockers such as diltiazem or verapamil may be viable alternatives. 
The reported prevalence of inducing gingival enlargement is 20% for diltiazem 
and 4% for verapamil [29]. In addition, consideration should be given to the use of 
another class of antihypertensive medications rather than calcium channel blockers. 
None of these drugs are known to induce gingival enlargement. Drug substitutions 
for cyclosporine are more limited.
Tacrolimus is another immunosuppressant that is used in organ transplant recipi-
ents [30]. The incidence of gingival enlargement in patients receiving tacrolimus 
therapy is approximately 65% lower than that in individuals who are receiving cyclo-
sporine [30]. Clinical trials have also shown that the substitution of cyclosporine 
with tacrolimus results in a significant decrease in the severity of gingival enlarge-
ment as compared with patients who are kept on cyclosporine therapy [31]. The use 
of azithromycin to decrease cyclosporine-induced gingival enlargement resulted 
in significantly greater changes than those observed with an improvement in oral 
hygiene. The topical administration of azithromycin in the form of a toothpaste also 
decreased the severity of cyclosporine-induced gingival enlargement [32, 33].
Secondly, biofilm control is a mandatory step and hence should be prioritize by 
the clinician in the treatment of drug-induced gingival enlargement. Although the 
exact role played by bacterial biofilm is not fully understood, evidence suggests that 
good oral hygiene, chemotherapeutic agents, and the frequent professional removal 
of biofilm decrease the degree of gingival enlargement and improve overall gingival 
health [27, 34]. Due to the presence enlarged gingival tissue, it is associated with 
pseudo-pocket formation and abundant biofilm accumulation, which may lead to 
the development of periodontitis. Hence, meticulous biofilm control helps to main-
tain attachment levels. In addition, adequate biofilm control may help to prevent 
the recurrence of gingival enlargement in surgically treated cases. Still in many 
patients, gingival enlargement persists after careful consideration of the previous 
two approaches. With these patients, surgical removal of the enlarged gingiva must 
be considered [6].
The recurrence of drug-induced gingival enlargement is a reality in surgically 
treated cases. The major cause of the recurrence of gingival enlargement is the dif-
ficulty with postsurgical oral hygiene. Meticulous home care, with a soft, postsurgi-
cal brush and chlorhexidine gluconate rinses, is indicated. Frequent professional 
cleanings can also help reduce the degree of recurrence [35].
4.7 Leukemic gingival enlargement
Leukemic enlargement occurs with acute or subacute leukemia, and it is uncom-
mon among patients in the chronic leukemic state. The patient’s blood profile 
including bleeding and clotting times and platelet count should be checked before 
treatment, and the hematologist should be consulted before periodontal treatment 
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is instituted. Gingival bleeding, sometimes spontaneous, is often associated with 
leukemic gingival enlargement. After subsiding of acute symptoms, attention is 
directed to correction of the gingival enlargement. Removal of local irritating fac-
tors helps in controlling the inflammatory component of the enlargement. Scaling 
and root planning is done to achieve it. The initial treatment steps consist of gently 
removing all loose debris with cotton pellets, performing superficial scaling, and 
instructing the patient in oral hygiene for biofilm control. This hygiene should 
include the daily use of chlorhexidine mouthrinses. Oral hygiene procedures are 
of supreme important for these patients. Definitive scaling and root planing are 
carried out at subsequent visits using local anesthesia (if required). Treatment 
sessions are confined to a small area of the mouth if hemostasis poses a challenge. 
Antibiotics are administered systemically the evening before and for a week after 
each treatment to reduce the risk of infection [6].
4.8 Gingival enlargement during pregnancy
The elimination of all local irritants that may be responsible for precipitating the 
gingival changes that occur during pregnancy should be done. This elimination is a 
preventive procedure to avoid any unfavorable situation as well as the treatment of 
gingival enlargement after it occurs. Marginal and interdental gingival inflammation 
and enlargement are treated by scaling and root planing. Treatment of tumor-like 
gingival enlargements consists of surgical excision, as well as the scaling and root 
planing of the tooth surfaces adjacent to the lesion. The enlargement may recur unless 
all irritants are removed. Food impaction is frequently an inciting factor. Gingival 
lesions during pregnancy should be treated as soon as they are detected, although not 
necessarily by surgical means. Scaling and root planing procedures and adequate oral 
hygiene measures may reduce the extent of the enlargement. Gingival enlargements do 
shrink after pregnancy, but they usually do not disappear. After pregnancy, the entire 
periodontal status of the patient should be reevaluated, and comprehensive treatment 
should be undertaken. Lesions should be removed surgically during pregnancy if 
they interfere with mastication or produce an esthetic disfigurement that bothers the 
patient. During pregnancy, the emphasis should be on (1) preventing gingival disease 
before it occurs and (2) treating existing gingival disease before it worsens [14].
4.9 Gingival enlargement during puberty
Gingival enlargement during puberty should be treated by phase I therapy, 
removal of all local irritant factors, controlling and removing the biofilm. Surgical 
removal is considered in severe cases and after instituting scaling and root planing. 
Oral hygiene measures are reinforced as high chances of recurrence is anticipated 
otherwise. Maintenance therapy is recommended [6].
4.10 Idiopathic enlargement
It usually requires surgical correction. Phase I therapy is undertaken to remove 
any source of irritants. Inflammatory component if present should be controlled. 
Functional and esthetic correction using a surgical therapy is undertaken depend-
ing on presence or absence of loss of attachment.
According to several authors, the best time is when all of the permanent denti-
tion has erupted, because the risk of recurrence is higher before it [36]. Emerson 
demonstrated that the degree of enlargement did not appear to be related to the oral 
hygiene or to the amount of calculus present and that a correct physiologic contour 
of the marginal gingiva is more important to prevent recurrence [37] (Table 1).
Gingival Disease - A Professional Approach for Treatment and Prevention
14
5. Surgical techniques for correction of gingival enlargement
5.1 Gingivectomy
Gingivectomy implies to the excision of gingival. The pocket wall (or enlarged 
tissue) is removed for accessibility.
Indications [38]: (1) elimination of suprabony pockets if the pocket wall is 
fibrous and firm, (2) elimination of gingival enlargements and (3) elimination of 
suprabony periodontal abscesses.
Contraindications to gingivectomy include the following: (1) access to bone 
required (2) narrow zone of keratinized tissue (3) esthetics particularly in the 
anterior maxilla (4) patients with high postoperative risk of bleeding (5) situations 
in which the bottom of the pocket is apical to the mucogingival junction.
Advantages: ease and simplicity of the procedure.
Disadvantages: more postoperative discomfort, increased chance of postoperative 
bleeding, sacrifices keratinized tissue and does not allow for osseous recontouring [3].
5.1.1 Gingivectomy procedures
In the latter part of the nineteenth century Robicsek (1884) pioneered gingivec-
tomy procedure. Grant (1979) defined gingivectomy as being “the excision of the 
soft tissue wall of a pathologic periodontal pocket”. The surgical procedure included 
Table 1. 
Treatment plan for gingival enlargement [44].
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elimination of pocket as well as osseous recontouring. Zentler (1918) later described 
a different technique [3].
Robicsek described a straight line incision to resect the gingival tissue while 
Zentler advocated a scalloped incision, first on the labial and then on the lingual sur-
face of each tooth, the diseased tissue should be loosened and lifted out by means of a 
hook-shaped instrument. The soft tissues are removed and alveolar bone is exposed. 
The bone is scraped and debrided. The wound is then covered with some kind of anti-
bacterial gauze or be painted with disinfecting solutions. Eradication of the deepened 
periodontal pocket and an area which can be easily maintained is expected [3].
5.2 Technique
The gingivectomy procedure as it is employed today was described in 1951 by 
Goldman (Figures 11–16) [3]
• After anesthesia of the affected area, the depths of pathological pockets are 
assessed using a periodontal probe. Bottom of the pocket is assessed and 
bleeding points are marked with a probe. Alternatively a pocket marker is used 
and bottom of the pocket is marked using the toothed end. The calibrated end 
is inserted into and measures the pocket. The bleeding points are used to guide 
the incision and to determine the depth of the tissue to be resected.
• The incision is given using scalpel or a Kirkland knife No. 15/16, maintaining the 
scalloping and festooning of the gingiva. The area with more bulky tissue will have 
more apically placed incision. In areas of thin gingival a less accentuated bevel 
is needed. The angulation of the incision is eternal bevel (45 degree towards the 
coronal portion). The incision is directed towards the base of the pocket and crest 
of the bone. Care should be observed to avoid exposure of bone. Physiologic con-
tour of gingival should be established. Incision may be continuous or interrupted.
• After completing the incision, the interdental soft tissue is separated by a sec-
ondary incision using an Orban knife (No. 1 or 2) or a Waerhaug knife (No. 1 or 
2; a saw-toothed modification of the Orban knife). Tissues are then separated 
using a curette. Tissue nippers are used to remove tissue tags and obtain smooth 
margins. Scaling and root planning is done to remove plaque and calculus.
• Probing should be done to assess for any remaining pockets if present. 
Rotatory instruments may be used to correct gingival contour, if necessary.
• Periodontal dressing is applied for protection of the surgical area. The dressing 
should be closely adapted to the buccal and lingual wound surfaces as well as to 
the interproximal spaces.
• Dressing should be given for 7 days. If necessary (depending on the heal-
ing and area of wound) dressing should remain in position for 10–14 days. 
Postoperative antibiotics and analgesics should be advised. Chlorhexidine 
gluconate (0.2%) mouthwash should be prescribed for oral hygiene.
5.2.1 Gingivectomy by electrosurgery
Gingivectomy can be done using electrosurgical unit. It provides hemostasis 
and proper contouring of the tissue. Use of electrosurgery also facilitates easy tissue 
incision accompanied with a strong hemostatic effect [39]. However, it is contrain-
dicated in patients with cardiac pacemaker. Any contact to bone or cementum has to 
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Figure 14. 
Gingivectomy: after removal of excess tissue.
Figure 12. 
Gingivectomy: marking the pockets using pocket marker.
Figure 13. 
Gingivectomy: incision given using Kirkland knife.
Figure 11. 
Gingivectomy: measuring the pockets using periodontal probe.
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be avoided as irreparable damage is caused. Needle electrode is used for removal of 
enlarged tissue. Festooning and shaping can be done using ovoid or diamond shaped 
electrode. Electrode is activated in concise shaving motion making brief contact with 
the tissues in cut phase. Prolonged contact will result in charring of tissue. A ball 
electrode is used for control hemorrhage in coagulation phase (Figures 17–19).
5.2.2 Gingivectomy by laser
Soft tissue lasers are used for treatment of gingival enlargement. Commonly  
used lasers are carbon dioxide (CO2) and the neodymium:yttrium-aluminum-gar-
net (Nd:YAG), which have wavelengths of 10,600 and 1064 nm, respectively. Proper 
protection should be observed along with eyewear and avoidance of any reflective 
surfaces. The procedure is similar to that of electrosurgery. Laser tip is used instead 
Figure 15. 
Gingivectomy: periodontal dressing given.
Figure 16. 
Gingivectomy: postoperative view after 1 month.
Figure 17. 
Gingivectomy by electrosurgery: preoperative view.
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of electrodes for cutting and coagulation. Compared with the use of a conventional 
scalpel, lasers can cut, ablate and reshape the oral soft tissue more easily, with no or 
minimal bleeding and little pain as well as no or only a few sutures. Laser surgery 
occasionally requires no local anesthetic, or only a topical anesthetic [40].
5.2.3 Gingivectomy by chemosurgery
Chemicals can be used to remove gingival tissue. About 5% paraformaldehyde 
[41] or potassium hydroxide [42] has been used in the past. Epithelialization and 
reformation of the junctional epithelium and reestablishment of the alveolar crest 
fiber system occur more slowly in chemically treated gingival wounds than in those 
produced by a scalpel [43]. However due to inability in controlling depth of action 
and delayed healing response, it is not used anymore.
The gingivectomy procedures cannot be used in cases of attachment loss or if the 
bone exposure is required. Thus flap surgery is undertaken in such cases.
5.3 Flap surgery
The flap surgical technique is as follows [14]:
1. After adequate anesthesia, bone sounding is performed with periodontal probe 
to determine the presence and extent of bone deformities. Depths of periodontal/
pathological pockets are also assessed.
2. Incision is given on buccal and lingual aspects using a #15 surgical blade. The 
initial scalloped internal bevel incision is made at least 3 mm coronal to the 
mucogingival junction, which includes the creation of new surgical interdental 
papillae in each interproximal space.
Figure 18. 
Gingivectomy by electrosurgery: incision with electrode tip.
Figure 19. 
Gingivectomy by electrosurgery: postoperative view after 1 month.
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3. Using the same blade gingival tissues are thinned in the buccolingual direction 
to the mucogingival junction. The blade establishes contact with the alveolar 
bone, and a full-thickness or split-thickness flap is elevated.
4. A similar scalloped internal bevel incision is given on the palatal aspect at a 
point where postoperative gingival margin is intended (at cementoenamel junc-
tion or at the bone crest in case of attachment loss). Thinning of palatal flap is 
done till the apical extent of the flap. The mucoperiosteal flap is then elevated.
5. Interdental incision is given with the help of an Orban knife, the base of each 
papilla connected to facial and lingual incisions is released.
6. Crevicular incisions are made on buccal, lingual and palatal areas to detach the 
collar of tissue. The collar of tissue is removed using curettes.
7. Tissues tags are removed using tissue scissors. The roots surfaces are thor-
oughly debrided.
8. Flap is replaced on to tooth bone junction and secured using interrupted or 
continuous mattress suture. Periodontal dressing is placed.
9. Sutures and dressing is removed after 1–2 weeks depending on the healing of 
the surgical area.
10. Postoperative antibiotics and analgesics are prescribed. Chlorhexidine gluco-
nate mouthwash (0.2%) is given for plaque control.
6. Conclusion
Gingival enlargement is of prime concern to the patient as it impairs both 
function and esthetics. In excessive enlargement cases, a properly timed surgical 
procedure to reduce the tissue to a normal contour to reduce the tissues to a normal 
contour will yield maximum benefit to the patient, reducing the number of clinical 
visits needed and improving the patients’ quality of life.
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